Maine legislation · 132nd Legislature
Maine LD697: An Act to Direct the Maine Prescription Drug Affordability Board to Assess Strategies to Reduce Prescription Drug Costs and to Take Steps to Implement Reference-based Pricing
Status: Signed into law, January 11, 2026
What the bill says
An Act to Direct the Maine Prescription Drug Affordability Board to Assess Strategies to Reduce Prescription Drug Costs and to Take Steps to Implement Reference-based Pricing.
From the engrossed text:
An Act to Direct the Maine Prescription Drug Affordability Board to Assess Strategies to Reduce Prescription Drug Costs and to Take Steps to Implement Reference-based Pricing Sec. 1. 5 MRSA §2041, sub-§2, as repealed and replaced by PL 2021, c. 293, Pt. A, §5, is amended to read: 2. Membership. The board has 5 consists of 6 members with expertise in health policy, health care data, health care economics or clinical medicine, who may not be affiliated with or represent the interests of a pharmaceutical manufacturer or a public payor, as that term is defined in section 2042, and who are appointed as follows: A. Two members appointed by the President of the Senate. The President of the Senate shall also appoint one alternate board member who will participate in deliberations of the board in the event a member appointed by the President of the Senate elects to be recused as provided in subsection 7, paragraph B; B. Two members appointed by the Speaker of the House of Representatives. The Speaker of the House of Representatives shall also appoint one alternate board member who will participate in deliberations of the board in the event a member appointed by the Speaker of the House of Representatives elects to be recused as provided in subsection 7, paragraph B; and C. One member …
Sponsors
- Cameron Reny (D, 13) · primary sponsor
- Donna Bailey (D, 31)
- Henry Ingwersen (D, 32)
- Anne-Marie Mastraccio (D, 142)
- Kristi Mathieson (D, 151)
- Joseph Rafferty (D, 34)
- Denise Tepler (D, 24)
Latest actions
- : HELD BY THE GOVERNOR.
- : PASSED TO BE ENACTED, in concurrence.
- : PASSED TO BE ENACTED. Sent for concurrence. ORDERED SENT FORTHWITH.
- : The House RECEDED and CONCURRED to PASSAGE TO BE ENGROSSED as Amended by Committee Amendment "A" (S-159) as Amended by Senate Amendment "A" (S-459) thereto.ORDERED SENT FORTHWITH.
- : On motion by Senator ROTUNDO of Androscoggin taken from the Special Appropriations Table On motion by Same Senator the Senate SUSPENDED THE RULES to RECONSIDER their actions whereby the Bill was PASSED TO BE ENGROSSED AS AMENDED by Committee Amendment "A" (S-159) On further motion by Same Senator the Senate SUSPENDED THE RULES to RECONSIDER their actions whereby Committee Amendment "A" (S-159) was ADOPTED. On further motion by Same Senator Senate Amendment "A" (S-459) to Committee Amendment "A"
- : On motion by Senator ROTUNDO of Androscoggin PLACED ON THE SPECIAL APPROPRIATIONS TABLE pending ENACTMENT in concurrence
- : PASSED TO BE ENACTED. Sent for concurrence. ORDERED SENT FORTHWITH.
- : Reports READ.On motion of Representative MATHIESON of Kittery, the Majority Ought to Pass as Amended Report was ACCEPTED.ROLL CALL NO. 249(Yeas 125 - Nays 9 - Absent 17 - Excused 0)The Bill was READ ONCE.Committee Amendment "A" (S-159) was READ and ADOPTED.Under suspension of the rules, the Bill was given its SECOND READING without REFERENCE to the Committee on Bills in the Second Reading.The Bill was PASSED TO BE ENGROSSED as Amended by Committee Amendment "A" (S-159). In concurrence. ORDERED S
- : Taken from the table by the President On motion by Senator BAILEY of York The Majority Ought to Pass As Amended Report ACCEPTED. PREVAILED Roll Call Ordered Roll Call Number 269 Yeas 35 - Nays 0 - Excused 0 - Absent 0 Bill READ ONCE Committee Amendment "A" (S-159) READ and ADOPTED Under suspension of the Rules, READ A SECOND TIME and PASSED TO BE ENGROSSED AS AMENDED by Committee Amendment "A" (S-159) Sent down for concurrence
- : Reports READ On motion by Senator BAILEY of York Tabled until Later in Today's Session, pending ACCEPTANCE OF EITHER REPORT. Unfinished Business
Votes
- House RC #249: ACC MAJ OTP AS AMENDED REP (June 2, 2025): 125 yea, 9 nay, passed
- Senate RC #269: ACCEPT MAJORITY OUGHT TO PASS AS AMENDED REPORT (May 29, 2025): 35 yea, 0 nay, passed
Common questions
- What is LD697?
- LD697 is a bill in the Maine Legislature (132nd Legislature): An Act to Direct the Maine Prescription Drug Affordability Board to Assess Strategies to Reduce Prescription Drug Costs and to Take Steps to Implement Reference-based Pricing.
- What does LD697 do?
- In its own words: An Act to Direct the Maine Prescription Drug Affordability Board to Assess Strategies to Reduce Prescription Drug Costs and to Take Steps to Implement Reference-based Pricing.
- What is the status of LD697?
- Signed into law as of January 11, 2026. Latest action: HELD BY THE GOVERNOR. (July 8, 2025).
- Who sponsored LD697?
- Cameron Reny (D, 13), with 6 co-sponsors.
- Where is the official record for LD697?
- On the Maine Legislature website: https://legislature.maine.gov/legis/bills/display_ps.asp?LD=697&snum=132
Source: official Maine record. Tracked by Delilah, AI for legislation across all 50 states and Congress.